Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Ataxin-2 Rabbit Polyclonal Antibody

Product Specifications

Background

Ataxin 2 (ATXN2) Homo sapiens This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The protein is primarily localized to the Golgi apparatus, with deletion of the Golgi and endoplasmic reticulum signals resulting in abnormal subcellular localization. In addition, the N-terminal region contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerdisease:Defects in ATXN2 are the cause of spinocerebellar ataxia type 2 (SCA2) [MIM:183090]; also known as olivopontocerebellar atrophy II (OPCA II or OPCA2) . Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA2 is characterized by hyporeflexia, myoclonus and action tremor and dopamine-responsive parkinsonism. SCA2 is caused by expansion of a CAG repeat in the coding region of ATXN2. Longer expansions result in earlier onset of the disease. In some patients with smaller CAG repeat expansions, SCA2 presents as pure familial parkinsonism without cerebellar signs., polymorphism:The poly-Gln region of ATXN2 is polymorphic: 17 to 29 repeats in the normal population, expanded to about 36 to 52 repeats in spinocerebellar ataxia 2 (SCA2) patients., similarity:Belongs to the ataxin-2 family., subunit:Monomer (By similarity) . Can also form homodimers., tissue specificity:Expressed in the brain, heart, liver, skeletal muscle, pancreas and placenta. Isoform 1 is predominant in the brain and spinal cord while isoform 4 is more abundant in the cerebellum. In the brain, broadly expressed in the amygdala, caudate nucleus, corpus callosum, hippocampus, hypothalamus, substantia nigra, subthalamic nucleus and thalamus.

Product Name Alternative

ATXN2; ATX2; SCA2; TNRC13; Ataxin-2; Spinocerebellar ataxia type 2 protein; Trinucleotide repeat-containing gene 13 protein

Gene Name

ATXN2

Gene ID

6311

Swiss Prot

Q99700

Host

Rabbit

Reactivity

Human, Rat, Mouse

Clonality

Polyclonal

Conjugation

Unconjugated

Applications

WB, IHC, ICC/IF, ELISA

Purification

Affinity purification

Dilution

WB 1:500-1:2000, IHC 1:100-1:300, ICC/IF 1:50-1:200, ELISA 1:10000-1:20000

Form

Liquid

Buffer

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% New type preservative N.

Modification

Unmodified

Molecular Weight

140kDa

Storage Conditions

Store at 4°C short term. Aliquot and store at -20°C for 12 months. Avoid freeze/thaw cycles.

Isotype

IgG

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Human anti-human alpha synuclein mAb (C7)
E4A09N07-C7 50 µg

Human anti-human alpha synuclein mAb (C7)

Ask
View Details
PDCD1 (Programmed Cell Death 1, Programmed Cell Death Protein 1, CD279, HGNC:8760, hPD-1, PD1, PD-1, Protein PD-1, SLEB2) (MaxLight 405) discontinued
P3120-61L-ML405 100 µL

PDCD1 (Programmed Cell Death 1, Programmed Cell Death Protein 1, CD279, HGNC:8760, hPD-1, PD1, PD-1, Protein PD-1, SLEB2) (MaxLight 405) discontinued

Ask
View Details
Lentiviral human GET3 shRNA (UAS) - Lentiviral human GET3 shRNA (UAS, GFP) (100)
GTR15096597 1 Vial

Lentiviral human GET3 shRNA (UAS) - Lentiviral human GET3 shRNA (UAS, GFP) (100)

Ask
View Details
Receptor tyrosine-protein kinase erbB-2 Phospho-Tyr1221/Y1222 (ERBB2 pY1221/Y1222) Antibody
abx330076-01 50 µg

Receptor tyrosine-protein kinase erbB-2 Phospho-Tyr1221/Y1222 (ERBB2 pY1221/Y1222) Antibody

Ask
View Details
Receptor tyrosine-protein kinase erbB-2 Phospho-Tyr1221/Y1222 (ERBB2 pY1221/Y1222) Antibody
abx330076-02 100 µg

Receptor tyrosine-protein kinase erbB-2 Phospho-Tyr1221/Y1222 (ERBB2 pY1221/Y1222) Antibody

Ask
View Details
TSPAN8 (INSERM patent CO-029) discontinued
048629 100 µg

TSPAN8 (INSERM patent CO-029) discontinued

Ask
View Details